key: cord-0715956-r790pqz6
authors: Kimball, Ethan; Buchwalder, Kyle; Upchurch, Cameron; Kea, Bory
title: Intermittent complete heart block with ventricular standstill after Pfizer COVID‐19 booster vaccination: A case report
date: 2022-04-20
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12723
sha: 388502702443afc3afc1b4a980688c4e618bfa59
doc_id: 715956
cord_uid: r790pqz6

As the COVID‐19 pandemic continues around the globe, vaccines are undoubtedly central to the fight to control the spread of the virus. However, as with any therapy, these vaccines are not without side effects. Documented cardiac complications of COVID‐19 vaccination include myocarditis, pericarditis, and cardiac conduction abnormalities. Here, we report a novel case of intermittent complete heart block with ventricular standstill occurring within 24 hours of administration of a Pfizer‐BioNTech COVID‐19 booster vaccine. The patient presented to the emergency department (ED) via ambulance for evaluation of syncope. On arrival, the patient lost pulses as a result of intermittent complete heart block with ventricular standstill. He required cardiopulmonary resuscitation (CPR) with intubation, transcutaneous pacing, and subsequent transvenous pacing in the ED. After stabilization and extensive workup, the patient was diagnosed with lymphocytic myocarditis and complete heart block that is suspected to be secondary to COVID‐19 booster vaccination. Ultimately, the patient's complete heart block resolved spontaneously, and he was discharged home with ambulatory rhythm monitoring.

Since the beginning of the COVID-19 pandemic, more than 493 million individuals have been infected with the virus and more than 6.1 million individuals have died. 1 Despite social distancing measures, quarantines, and mask mandates, the virus continues to spread across the globe. States. [2] [3] [4] The Pfizer-BioNTech COVID-19 vaccine is associated with a number of common side effects including local pain, fatigue, chills, and fever. 3 However, more rare and serious reactions have occurred after administration of these vaccines. Documented cardiac complications include myocarditis, pericarditis, and cardiac arrhythmias. Although both myocarditis and pericarditis have been reported with some frequency in the literature, cardiac conduction abnormalities have been less prevalent. [5] [6] [7] Ours is the first reported case of intermittent complete heart block with ventricular standstill secondary to lymphocytic (Figure 3 ).

The patient was discharged home on hospital day 12 without 

Vaccines remain critical in the fight to end the ongoing COVID-19 pandemic. To date, more than 500 million COVID-19 vaccine doses have been administered in the United States. 9 Given the prevalence of these 

published a case of non-high grade AV block after administration of the Chinese COVID-19 BBIBP-CorV vaccine. 13 However, ours is the first reported case of paroxysmal complete heart block with ventricular standstill secondary to lymphocytic myocarditis suspected to be due to administration of the Pfizer COVID-19 vaccine.

This case report should not be taken as a refutation of mRNA vaccine technology broadly or the Pfizer-BioNTech COVID-19 vaccine more specifically. Although, cases of vaccine-induced myocarditis occur, studies suggest that COVID-19 infection results in an increased incidence of myocarditis when compared to vaccination-40 per 1 million versus 1-10 per 1 million, respectively. Likewise, the incidence of cardiac arrhythmia appears to be much higher after COVID-19 infection than vaccination. 14 Further, numerous cases of complete heart block have been documented after COVID-19 infection. 15 On a population basis, vaccination remains safe and beneficial. 6 Nevertheless, emergency medicine physicians must be aware of possible rare but serious side effects related to COVID-19 vaccination, including both myocarditis and paroxysmal complete heart block with ventricular standstill, and of how to support similarly critically ill patients.

We present a case of a patient presenting to the ED with syncope from intermittent complete heart block with ventricular standstill secondary to lymphocytic myocarditis suspected to be due to Pfizer-BioNTech COVID-19 vaccine administration.

Geneva: World Health Organization

COVID-19 Vaccine (also known as COMIRNATY) Overview and Safety

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting

COVID-19 vaccine and myocarditis

Myocarditis with COVID-19 mRNA vaccines. Circulation

From muscles to wires: report of two cases and literature review on COVID-19 vaccination and cardiac conduction disturbance

Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule

Centers for disease control and prevention

Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics

Myocarditis temporally associated with COVID-19 vaccination

Myocarditis after BNT162b2 and mRNA-1273 vaccination

COVID-19 BBIBP-CorV vaccine and transient heart block -a phenomenon by chance or a possible correlation -a case report

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Heart block in patients with coronavirus disease 2019: A case series of 3 patients infected with SARS-CoV-2. HeartRhythm Case Rep